AstraZeneca PLC share price logo

AstraZeneca PLC

NASDAQ: AZN

Mega Cap

$154.22

-15.42

(-9.09%)

Live

as on

AstraZeneca PLC Stock Performance

as on August 4, 2026 at 2:13 am IST

  • Day's High

    $154.22
    $159.12

    3.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $72.90
    $212.71
    downward going graph

    52.73%

    Downside

    37.93%

    Upside

    downward going graph

AstraZeneca PLC share price movements today

Previous Close
$169.64
Open
$157.24
Volume
5.0M
Day's Low - High
$154.22 - $159.12
52 Week Low - High
$72.90 - $212.71

AstraZeneca PLC Historical Returns

1 Month Return
-13.07 %
3 Month Return
-8.17 %
1 Year Return
+ 129.4 %
3 Year Return
+ 143.49 %
5 Year Return
+ 194.21 %

AstraZeneca PLC Stock Fundamentals & Key Indicators

Check AstraZeneca PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$263.1B

EPS (TTM)

10.085

Dividend Yield

1.89%

Quarterly Earnings Growth YOY

0.03%

PE Ratio (TTM)

25.4

Industry PE ratio

23.38125

PEG Ratio

1.4533

EBITDA

19.9B

Revenue (TTM)

61.4B

Profit Margin

17.02%

Return On Equity TTM

21.97%

AstraZeneca PLC Stock Valuation

Track how AstraZeneca PLC P/E has moved over time to understand its valuation trends.

AstraZeneca PLC in the last 5 years

  • Overview

  • Trends

Lowest (16.71x)

March 31, 2025

Industry (23.38x)

August 3, 2026

Today (25.40x)

August 3, 2026

Highest (49.60x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 25.40x

AstraZeneca PLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AstraZeneca PLC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
AstraZeneca PLC image
AstraZeneca PLC
BUY$263.1B194.21%25.417.02%1.8900000000000001%
Eli Lilly & Co. image
Eli Lilly & Co.
BUY$1.0T348.78%40.8134.99%0.54%
ABBVIE INC. image
ABBVIE INC.
BUY$443.4B115.86%70.899.80%1.31%
Johnson & Johnson image
Johnson & Johnson
BUY$617.8B47%29.7721.48%2.0500000000000003%
Merck & Co. Inc. image
Merck & Co. Inc.
BUY$307.2B70.4%36.6813.59%2.53%

Stock Returns calculator for AstraZeneca PLC Stock including INR - Dollar returns

The AstraZeneca PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

AstraZeneca PLC investment value today

Current value as on today

₹2,26,754

Returns

₹1,26,754

(+126.75%)

Returns from AstraZeneca PLC Stock

₹1,08,546 (+108.55%)

Dollar Impact

₹18,207 (+18.21%)

Analyst Recommendation on AstraZeneca PLC Stock

Based on 38 analysts

BUY

81.58%

Buy

15.79%

Hold

2.63%

Sell

Based on 38 analysts, 81.58% of analysts recommend a 'BUY' rating for AstraZeneca PLC. Average target price of $213.69

AstraZeneca PLC Share Price Target

Get share price movements and forecasts by analysts on AstraZeneca PLC.

What analysts predicted

27.83%UPSIDE

Target Price

$213.69

Current Price

$154.22

Analyzed by

38 Analysts

Target

$213.69

AstraZeneca PLC target price $213.69, a slight upside of 27.83% compared to current price of $154.22. According to 38 analysts rating.

Indian Investors' Interest in AstraZeneca PLC Stock

Investment in AstraZeneca PLC Shares on INDmoney has grown by 12.79% in the last 30 days, indicating increased investment activity.

Time period: to

Change:12.79% versus previous 30 day period

Search interest for AstraZeneca PLC Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

AstraZeneca PLC Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
12,679
12,938
13,565
14,891
13,588
14,457
15,191
15,503
15,288
15,194
Gross Profit
10,461
10,755
10,484
12,166
11,347
11,984
12,390
12,385
12,610
11,175
Operating Income
3,115
2,746
2,106
2,036
3,674
3,508
3,583
2,978
4,246
3,073
EBITDA
4,468
4,119
4,102
2,809
5,035
4,955
5,227
4,612
5,673
4,978
Interest Expense
413
443
457
429
349
439
434
472
393
429
Depreciation
-
-
1,817
714
1,284
1,389
1,549
1,511
1,366
1,929
Income Before Tax
2,800
2,397
1,828
1,666
3,402
3,127
3,244
2,629
3,914
2,764
Income Tax Expense
620
469
395
166
481
679
709
300
833
287
Net Income
2,179
1,927
1,429
1,500
2,916
2,450
2,533
2,326
3,080
2,476
Net Profit Margin
17.19%
14.89%
10.53%
10.07%
21.46%
16.95%
16.67%
15.00%
20.15%
16.30%

AstraZeneca PLC Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23,002
22,465
22,090
24,384
26,617
37,417
44,351
45,811
54,073
58,739
Gross Profit
18,876
18,147
17,154
19,463
21,318
24,980
31,960
37,543
43,866
48,106
Operating Income
4,902
3,677
3,387
2,924
5,162
1,056
3,757
8,193
10,003
13,743
EBITDA
7,276
6,623
7,112
6,712
8,084
5,113
9,085
13,422
15,438
19,829
Interest Expense
1,367
1,360
1,366
1,402
1,272
1,276
1,330
1,589
1,682
1,694
Depreciation
-
-
-
-
-
4,102
5,254
4,934
5,065
5,733
Income Before Tax
3,552
2,227
1,993
1,548
3,916
-265
2,501
6,899
8,691
12,402
Income Tax Expense
146
-641
-57
321
772
-380
-792
938
1,650
2,169
Net Income
3,499
3,001
2,155
1,335
3,196
112
3,288
5,955
7,035
10,255
Net Profit Margin
15.21%
13.36%
9.76%
5.47%
12.01%
0.30%
7.41%
13.00%
13.01%
17.46%

AstraZeneca PLC Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2,397
1,828
1,666
2,916
3,127
2,533
2,356
3,914
2,476
Operating Cash Flow
3,085
3,383
2,907
3,713
3,386
5,134
2,430
3,359
2,887
Investing Cash Flow
-2,872
-1,514
-1,181
-1,253
-2,108
-2,001
-1,521
-1,792
-2,931
Financing Cash Flow
-1,222
-4,131
-671
-2,707
518
-2,078
-3,356
267
-2,554
Change in Cash
-1,015
-2,242
994
-222
1,825
1,048
-2,410
1,816
-2,691

AstraZeneca PLC Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,227
1,993
1,548
3,916
-265
2,501
6,899
8,691
10,225
Operating Cash Flow
3,578
2,618
2,969
4,799
5,963
9,808
10,345
11,861
14,575
Investing Cash Flow
-2,328
963
-657
-285
-11,058
-2,960
-4,064
-7,980
-6,808
Financing Cash Flow
-2,936
-2,044
-1,765
-2,203
3,649
-6,823
-6,567
-3,996
-7,544
Change in Cash
-1,752
1,499
552
2,323
-1,508
-55
-346
-208
269

Global Institutional Holdings in AstraZeneca PLC

Funds
Holdings
Atlantic Trust Group, LLC
0.27%
Vanguard Capital Management, LLC
2.9%
Ameriprise Financial Inc
0.16%
Capital Research & Mgmt Co - Division 3
2.22%
Boston Partners Global Investors, Inc
0.16%
See all

AstraZeneca PLC News & Key Events

  • img

    Today's Timeline - 03 August

    Mon, 11:51 AM

    -

    AstraZeneca and Bristol Myers Squibb held talks for a potential $400 billion merger.

    Mon, 12:47 PM

    -

    AstraZeneca shares dropped 7% after reports of merger discussions with Bristol Myers Squibb.

    Mon, 05:05 PM

    -

    AstraZeneca shares fell over 4% amid merger talks with Bristol Myers Squibb.

  • img

    Today's Timeline - 03 August

    Mon, 05:57 PM

    -

    Market speculation arises as AstraZeneca and Bristol Myers Squibb engage in merger discussions.

    Mon, 06:12 PM

    -

    AstraZeneca discusses potential merger with Bristol-Myers Squibb, creating a $400 billion pharmaceutical giant.

Insights on AstraZeneca PLC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AZN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, AZN stock has moved up by 129.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AZN has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    AstraZeneca PLC has experienced a decline in net profit over the last two quarters. The net profit decreased from $3.08 billion to $2.47 billion, representing an average decrease of 19.6% per quarter.

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    AstraZeneca PLC has seen a decline in revenue over the last three quarters. The revenue decreased from $15.50 billion to $15.19 billion, resulting in an average decrease of 1.0% per quarter.

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
OrganisationAstraZeneca PLC
Headquarters1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
IndustryDrug Manufacturers - General
CEOMr. Pascal Claude Roland Soriot D.V.M., M.B.A.
E-voting on sharesClick here to vote

Key Management of AstraZeneca PLC

Name

Title

Dr. Ruud Dobber Ph.D.

Executive Vice-President of BioPharmaceuticals Business Unit

Mr. David Fredrickson

Executive Vice-President of Oncology Haematology Business Unit

Dr. Aradhana Sarin M.D.

CFO & Executive Director

Ms. Pam P. Cheng

EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board

Mr. Joris Silon

Head of Investor Relations

Ms. Iskra Reic

Executive Vice President of International

Ms. Ruth March FMEDSCI, O.B.E., Ph.D.

Senior VP of Precision Medicine - R&D Oncology

Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.

CEO & Executive Director

Mr. Jeffrey Pott J.D.

CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board

Dr. Susan Mary Galbraith M.D., Ph.D.

Executive Vice President of Oncology R&D

FAQs

What is AstraZeneca PLC share price today?

AstraZeneca PLC share price today is $154.22 as on . AstraZeneca PLC share today touched a day high of $159.12 and a low of $154.22.

What is the 52 week high and 52 week low for AstraZeneca PLC share?

AstraZeneca PLC share touched a 52 week high of $212.71 on and a 52 week low of $72.90 on . AstraZeneca PLC stock price today i.e. is trending at $154.22,which is 27.50% down from its 52 week high and 111.56% up from its 52 week low.

What is AstraZeneca PLC's market capitalisation today?

AstraZeneca PLC market capitalisation is $0.26T as on .

How to invest in AstraZeneca PLC Stock (AZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for AstraZeneca PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AstraZeneca PLC Shares that will get you 0.0097 shares as per AstraZeneca PLC share price of $154.22 per share as on August 3, 2026 at 8:43 pm IST.

What is the minimum amount required to buy AstraZeneca PLC Stock (AZN) from India?

Indian investors can start investing in AstraZeneca PLC (AZN) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in AstraZeneca PLC stock (as per the Rupee-Dollar exchange rate as on ). Based on AstraZeneca PLC share’s latest price of $154.22 as on August 3, 2026 at 8:43 pm IST, you will get 0.0648 shares of AstraZeneca PLC. Learn more about fractional shares .

What are the returns that AstraZeneca PLC has given to Indian investors in the last 5 years?

AstraZeneca PLC stock has given 194.21% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?